Cohen Fred E bought NTLA

January 5, 2026 · Form 4 insider transaction

Cohen Fred E bought 150,000 shares of Intellia Therapeutics, Inc. at $9.35 per share, a transaction worth $1.40M. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 2 days after the transaction.

Direction
Acquired (buy-side)
Shares
150,000
Price
$9.35
Total value
$1.40M
RoleDirector, 10% owner
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateJanuary 5, 2026
Filing dateJanuary 7, 2026
Shares owned after207,453
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

Reflects an open market purchase of shares of the Issuer's common stock by the Reporting Person in accordance with the Issuer's trading policies.; The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.13 to $9.68, inclusive. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares purchased by the reporting person on January 5, 2026 at each separate price.

View the original Form 4 on SEC EDGAR